George A Poultsides

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
  2. doi request reprint Hybrid resection of duodenal tumors
    George A Poultsides
    Division of Surgical Oncology, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    J Laparoendosc Adv Surg Tech A 21:603-8. 2011
  3. doi request reprint Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors
    Motaz Qadan
    Department of Surgery, Stanford University Hospital and Clinics, Stanford, CA
    J Am Coll Surg 218:188-95. 2014
  4. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
  5. pmc Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
    Walter G Park
    Department of Medicine, Stanford University, Stanford, California, USA
    Gastrointest Endosc 78:295-302.e2. 2013
  6. pmc Lymph nodes and survival in pancreatic neuroendocrine tumors
    Geoffrey W Krampitz
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Arch Surg 147:820-7. 2012
  7. pmc Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness
    David J Worhunsky
    Department of Surgery, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    HPB (Oxford) 16:304-11. 2014
  8. doi request reprint Intensity-modulated radiotherapy for pancreatic adenocarcinoma
    Jonathan A Abelson
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 82:e595-601. 2012
  9. pmc Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 19:1928-35. 2012
  10. ncbi request reprint Surgical management of neuroendocrine tumors of the gastrointestinal tract
    Lyen C Huang
    Department of Surgery, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    Oncology (Williston Park) 25:794-803. 2011

Collaborators

Detail Information

Publications19

  1. doi request reprint Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis
    George A Poultsides
    Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
    Ann Surg Oncol 19:2295-303. 2012
    ..Specifically, the prevalence and prognostic significance of radiographic calcifications in these tumors remains unclear...
  2. doi request reprint Hybrid resection of duodenal tumors
    George A Poultsides
    Division of Surgical Oncology, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    J Laparoendosc Adv Surg Tech A 21:603-8. 2011
    ....
  3. doi request reprint Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors
    Motaz Qadan
    Department of Surgery, Stanford University Hospital and Clinics, Stanford, CA
    J Am Coll Surg 218:188-95. 2014
    ..Currently, the American Joint Committee on Cancer (AJCC) recommends use of the pancreatic adenocarcinoma staging system for PNETs. We sought to explore the prognostic usefulness of the pancreatic adenocarcinoma staging system for PNETs...
  4. doi request reprint Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?
    Manali I Patel
    Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Ann Surg Oncol 20:1631-8. 2013
    ..We sought to validate the new system on a U.S. population database...
  5. pmc Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
    Walter G Park
    Department of Medicine, Stanford University, Stanford, California, USA
    Gastrointest Endosc 78:295-302.e2. 2013
    ..Better pancreatic cyst fluid biomarkers are needed...
  6. pmc Lymph nodes and survival in pancreatic neuroendocrine tumors
    Geoffrey W Krampitz
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Arch Surg 147:820-7. 2012
    ..Lymph node metastases decrease survival in patients with pancreatic neuroendocrine tumors (pNETs)...
  7. pmc Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness
    David J Worhunsky
    Department of Surgery, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    HPB (Oxford) 16:304-11. 2014
    ..However, a subset of these tumours can be hypoenhancing. The prognostic significance of the CT appearance of these tumors remains unclear...
  8. doi request reprint Intensity-modulated radiotherapy for pancreatic adenocarcinoma
    Jonathan A Abelson
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 82:e595-601. 2012
    ..To report the outcomes and toxicities in patients treated with intensity-modulated radiotherapy (IMRT) for pancreatic adenocarcinoma...
  9. pmc Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 19:1928-35. 2012
    ..Duodenal adenocarcinoma is a rare cancer usually studied as a group with periampullary or small bowel adenocarcinoma; therefore, its natural history is poorly understood...
  10. ncbi request reprint Surgical management of neuroendocrine tumors of the gastrointestinal tract
    Lyen C Huang
    Department of Surgery, Stanford University School of Medicine, Stanford, California 94305 5641, USA
    Oncology (Williston Park) 25:794-803. 2011
    ....
  11. doi request reprint Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the National Surgical Quality Improvement Program
    Jordan M Cloyd
    Department of Surgery, Stanford University, 300 Pasteur Dr, MC5641, Stanford, CA, 94305, USA
    J Gastrointest Surg 18:605-12. 2014
    ..The impact of chronic kidney disease (CKD) and end-stage renal disease on outcomes following major abdominal surgery is not well defined...
  12. ncbi request reprint Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion
    David J Worhunsky
    Division of Surgical Oncology, Department of Surgery, Stanford University Medical Center, 300 Pasteur Drive, Suite H3680C, Stanford, CA, 94305, USA
    J Gastrointest Surg 18:1445-51. 2014
    ..We found no advantage to either technique with respect to outcomes and splenic preservation. Operative approach should reflect technical considerations including location in the pancreas. ..
  13. pmc Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
    Zachary J Kastenberg
    Department of Surgery, Stanford University Medical Center, Stanford, CA 94305 5641, USA
    HPB (Oxford) 15:142-8. 2013
    ..The aim of the study was to evaluate the frequency and patterns of rehospitalization after a pancreaticoduodenectomy (PD)...
  14. pmc Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
    Brendan C Visser
    Department of Surgery, Stanford University Medical Center, CA 94305 5641, USA
    HPB (Oxford) 14:539-47. 2012
    ..We investigated variation in the management of pancreatic cancer (PC) among large hospitals in California, USA, specifically to evaluate whether compliance with NCCN guidelines correlates with patient outcomes...
  15. pmc Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection
    Jeffrey A Norton
    Department of Surgery, Stanford University Medical Center, Stanford, CA 94305 5641, USA
    Arch Surg 146:724-32. 2011
    ..Surgery for pancreatic endocrine tumors (PETs) with blood vessel involvement is controversial...
  16. pmc Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
    May T Tun
    Department of Medicine, Stanford University, Stanford, CA 94305, USA
    BMC Gastroenterol 12:15. 2012
    ..This study evaluated the diagnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts...
  17. doi request reprint Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy
    Jordan M Cloyd
    Department of Surgery, Stanford University, 300 Pasteur Dr, H3591, Stanford, CA, 94305, USA
    J Gastrointest Surg 18:348-53. 2014
    ..Early identification of patients at risk for developing pancreatic fistula (PF) after pancreaticoduodenectomy (PD) may facilitate prevention or treatment strategies aimed at reducing its associated morbidity...
  18. doi request reprint Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis
    Cindy Kin
    Department of Surgery, Stanford University School of Medicine, CA, USA
    Expert Rev Mol Diagn 13:581-99. 2013
    ..The detection and characterization of circulating tumor cells and cell-free DNA in colorectal cancer patients will not only improve the understanding of the development of metastasis, but may also supplant the use of other biomarkers. ..
  19. ncbi request reprint Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome
    George A Poultsides
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2797-804. 2012
    ..Histologically, dominant response patterns include fibrosis, necrosis and/or acellular mucin, but some of these changes can appear without previous chemotherapy and their individual correlation with outcome is unknown...